StageZero Life Sciences Launches COC Plus Worldwide
StageZero Life Sciences Launches COC Plus Worldwide
5/15/2022 TORONTO, ON / ACCESSWIRE / May 15, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, today announced the worldwide launch of the COC Plus Program for patients currently in the COC Protocol / TREAT Program. COC Plus is a new physician led program centered on nutrition and other health interventions to help address a patient's specific cancer and is designed to be used alongside standard of care.
Created by the physicians and scientists who developed the groundbreaking COC Protocol, COC Plus is centered on nutrition, supplements and other health interventions specifically designed to impact key blood biomarkers proven to influence cancer prognosis. The specialty lab panel and subsequent interventions developed by our team is not routinely ordered by oncologists or family physicians.
Our COC Plus Program includes:
- A lab order for a very specific set of blood tests to assess your metabolic and inflammatory status and guide our recommended interventions.
- A comprehensive physician consultation with an experienced metabolic oncologist to map your interventional strategy.
- And a Road Map to address any health issues with nutrition, supplements, and other strategies intended to improve health outcomes.
- Like the COC protocol, this program is designed to be adjunctive to standard-of-care treatments, not replace them.
"Many of our patients using the COC Protocol have been asking for expert guidance around nutrition, supplements, and other strategies that is currently not generally available to them. We've heard them and we're very pleased to announce our new COC Plus Program to help address just this need." said James Howard-Tripp, Chairman and CEO of StageZero Life Sciences. "Today's announcement builds on the Company's growth strategy and current program offerings and is available to all patients, worldwide".
To learn more about COC Plus, please visit https://careoncology.com/coc-plus/.